Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 274 No 7340 p289
12 March 2005

This article
Reprint   Photocopy

  Acrobat Reader


News summary

Related websites
Control of entry
Contract 2005


Regulations guidance explains entry test exemptions

The four exemptions

· Pharmacies based in approved retail areas over 15,000 sq m gross floor space away from town centres

· Pharmacies that intend to open for more than 100 hours a week

· Consortia establishing one-stop primary care centres

· Wholly mail-order or internet based pharmacy services

Controls will not apply in large edge-of-town complexes

Controls will not apply in large edge-of-town complexes

Draft guidance (PDF 650K) for primary care trusts in England on implementing the forthcoming NHS regulations explains how new exemptions to the control of entry test should be applied. As a general rule, any new pharmacy must be necessary or desirable to secure adequate pharmaceutical services in a particular neighbourhood. But the new contract introduces four exemptions (see Panel).

The guidance says that any number of pharmacies can be given NHS contracts in qualifying large retail developments without having to meet the “necessary or desirable” criteria. It explains how PCTs should decide whether any development meets the criteria for exemption, and suggests that a development within 300m of a town centre is unlikely to qualify.

Applicants seeking a contract under the 100-hour exemption will be allowed to set their own opening times, but must specify them in their applications. They will also have to explain how they will provide information to the PCT on the actual hours they have opened. Pharmacies that fail to provide services consistently for at least 100 hours may have their contracts cancelled.

Pharmacies at one-stop health centres will only be exempt from the control of entry tests if the centre is operated by a consortium. The pharmacy does not have to be part of the consortium, nor does it have to be operated by the consortium itself.

Pharmacies that gain contracts under the exemption for mail-order and internet pharmacies will be prohibited from offering face-to-face NHS services. They will be allowed to offer private pharmaceutical services and sell or supply goods that are not related to NHS services. PCTs will be expected to make sure that these constraints are met and that the pharmacies provide the full range of essential services.

The proposed guidelines also outline constraints on European pharmacists who gain automatic registration with the Royal Pharmaceutical Society. They say that such pharmacists will only be allowed to hold NHS dispensing contracts in England if the PCT is satisfied that the pharmacist has a good enough command of English to provide pharmaceutical services.

Steve Lutener, head of regulation at the Pharmaceutical Services Negotiating Committee, said: “The PSNC is currently considering and commenting on the draft guidance on control of entry. The new criteria of competition and choice as well as the four well publicised exemptions will need detailed guidance, as the information produced so far has dealt only with the principles and not the practical details. As control of entry has become more complex, it is important that the guidance is sound. We therefore welcome the decision by the Department of Health to invite comments, so that we can highlight areas where more clarity is required.”

The draft guidance will be modified or confirmed when the regulations appear — probably before the end of this month.

Back to Top


©The Pharmaceutical Journal